politics

Experts Warn USAID Cuts May Hinder Global Access to HIV Prevention Drug

31 Temmuz 2026The Guardian

Experts at the Aids 2026 Conference in Rio de Janeiro highlight that new innovations in HIV prevention, particularly the injectable PrEP drug lenacapavir, could significantly reduce global HIV cases. However, cuts to US foreign aid threaten access for those who need it most.
The World Health Organization has recommended prioritizing this medication, which is highly effective in preventing HIV when used consistently.
The decline in investment for HIV prevention comes at a time when new treatment options are becoming available. The World Health Organization's endorsement of lenacapavir reflects a growing recognition of the need for innovative solutions to combat the HIV epidemic.
The potential of lenacapavir to transform HIV prevention is overshadowed by the implications of funding cuts from the US. While the drug represents a significant step forward in public health, the lack of financial support could exacerbate existing inequalities in access to healthcare.

NewsAI özeti

This article is for informational purposes only and does not constitute medical advice.